Sapphiros, a privately-held consumer diagnostic company backed by KKR and Neoenta, has acquired Flexotronix Limited, a manufacturing company focused on developing manufacturing technologies and flexoprinted electronics.

Flexotronix has developed a printed electronics manufacturing line using proprietary conductive inks and printed components, including batteries connectivity capability and other diagnostic test control mechanisms. With this acquisition, these technologies will be deployed across the Sapphiros portfolio of companies to lower consumable costs and fully automate diagnostic testing and data management.

“The combined resources of Flexotronix and Sapphiros will ensure we are at the forefront of developing low-cost, high-performance diagnostics globally as well as preparation to rapidly respond to future biosecurity threats,” says Mark Gladwell, COO of Sapphiros. “We are pleased to welcome the talented Flexotronix team to Sapphiros.”